abstract |
The present invention relates to a bispecific antibody comprising at least one antigen binding site specific for DR5 and at least one antigen binding site specific for FAP, an antibody specific for DR5, a method for producing the same, and a method for producing the same A pharmaceutical composition of an antibody, and the use thereof. |